The University of KwaZulu-Natal is a university with five campuses in the province of KwaZulu-Natal in South Africa. It was formed on 1 January 2004 after the merger between the University of Natal and the University of Durban-Westville.

During the past decade, University of KwaZulu-Natal conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of KwaZulu-Natal" #1 sponsor was "University of KwaZulu" with 4 trials, followed by "AIDS Clinical Trials Group" with 2 trials sponsored, "Centers for Disease Control and Prevention" with 1 trials sponsored, "Oslo University Hospital" with 1 trials sponsored and "PATH" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of KwaZulu-Natal" #1 collaborator was "University of KwaZulu" with 4 trials as a collaborator, "Medical Research Council, South Africa" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "African Population and Health Research Center" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "University of KwaZulu-Natal" are "HIV" (3 trials), "HIV Infections" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials), "COVID-19" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "University of KwaZulu-Natal" in a lesser frequency.

Most popular intervention types in "University of KwaZulu-Natal" are "Drug" (5 trials), "Behavioral" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Emtricitabine" (1 trials), "Emtricitabine/Tenofovir disoproxil fumarate" (1 trials), "Enhanced Counseling" (1 trials), "Feeding buddies" (1 trials) and "Liberal transfusion strategy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of KwaZulu-Natal" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University of KwaZulu-Natal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in University of KwaZulu-Natal, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of KwaZulu-Natal, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".